HEMATOLOGICAL PROFILE IN UNCOMPLICATED TYPE 2 DIABETES MELLITUS PATIENTS

Dr. Ravi Patel, Dr. Richa Patel, Dr. Gopi Patel, Dr. Nilay Suthar, Dr. Dipak Solanki, Dr. Ajay Rathod

Abstract


INTRODUCTION:Diabetes mellitus (DM) is a non-communicable disease with increasing prevalence worldwide.Poorly controlled diabetes
leads to various complications such as nephropathy, retinopathy, neuropathy and oxidative stress causing oxidative damage to tissues and cells.The
concentration of HbA1c depends on the concentration of glucose in the plasma and the duration of hyperglycemia and is an index of diabetic
control for a period over past 12 weeks.Anemia, leucocytosis and thrombocytosis are common hematological finding in diabetic patients early
evaluation of this parameter prevent complications.
METHOD:The case-control study was carried out for 3 months duration at L.G.Hospital, Ahmdabad. All uncomplicated type -2 DM patients
visited to OPD or indoor were included in study. Hematological parameter of these patients compared with non-diabetics indivisuals.
RESULT: Statistically significant correlations observed in anemia(p<0.0001) and thrombocytosis(p= 0.004) between two groups. Mean WBCs
(8382/cumm vs 7917/cumm)count higher in diabetics than non-diabetics group but was not statistically significant(p=0.29).
CONCLUSION: Hematological profile in Diabetes patients is deranged and diabetics are more prone for anemia and thrombocytosis. Routine and
regular screening for hematological profile initiate early prevention strategies and reduce the morbidity related to it. Hence hematological
parameter should be done along with glucose profile for early assessment of disease progression and to prevent morbidity.


Keywords


Anemia, HbA1c, Leucocytosis, Type2 diabetics, Thrombocytosis.

Full Text:

PDF

References


Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-21.

Comazzi S, Spagnolo V, Bonfanti U. Erythrocyte changes in canine diabetes mellitus: in vitro effects of hyperglycaemia and ketoacidosis. J Comp Clin Path. 2004;12(4):199-205.

Hoffbrand AV, Moss PAH, Pettit JE. Erythropoiesis and general aspects of anaemia. Essential Haematology. Fifth ed. UK: Blackwell Publishing; 2006:18-20.

El-achkar TM, Ohmit SE, Mccullough PA, Crook ED, Brown WW, Grimm R, et al. Higher prevalence of anaemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney Int. 2005;67(4):1483-8.

Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anaemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care. 2001;24(3):495-9.

Mbata CA, Adegoke A, Nwagu C, Nyeso WA. Some Haematological parameters in diabetic patients in Port Harcourt Nigeria. AJMS. 2015;3(2): 2348–7186.

Mirza S, Hossain M, Mathews C, Martinez P, Pino P, Gay JL, et al. Type 2- diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican American: a cross-sectional study. Cytokine. 2012;57(1):136–42.

Gkrania-Klotsas E, Ye Z, Cooper AJ, Sharp SJ, Luben R, Biggs ML, et al. Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS One. 2010;5(10):e13405.

Evans TC, Jehle D. The red blood cell distribution width. The Journal of emergency medicine 1991;9Suppl 1:71–74

Magri C, Fava S. Red blood cell distribution width and diabetes-associated complications. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2014;8(1):13-17.

Chen LK, Ming-Hsien L, Zhi-Jun C, Shinn-Jang H, Chiou ST. Association of insulin resistance and hematologic parameters: study of a middle-aged and elderly Chinese population in Taiwan. Chin Med Assoc. 2006;69(6):248–53.

Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol. 2008;2(6):1130–8.

Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K. White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men. Diabetologia. 2002;45:42–8.

Alam J, Chandra SM, Mokarrama MN, Hoque M, Hasan M, Islam S, et al. A comparative analysis of biochemical and hematological parameters in diabetic and non-diabetic adults. AMS. 2015;2(1):1–9.

Kakouros N, Rade JJ, Kourliouros A, Resar JR. Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol. 2011;2011:742719.

Hekimsoy Z, Payzinb B, Ornek T, Kandog˘an G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications.2004;18:173–176.

International Diabetes Federation Guideline Development Group. Global guideline for type 2 Diabetes. Diabetes Res Clin Pract. 2014; 1041–1052.

Mortensen SB, Larsen SB, Grove EL, Kristensen SD, Hvas AM. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus. Thromb Res. 2010;126(4):e318–e322

Rodriguez-Manas L, Arribas S, Giron C, Villamor J, Sanchez-Ferrer C, Marin J. Interference of glycosylated human hemoglobin with endothelium- dependent responses. Circulation 1993; 88(5):2111-2116.

Harish Kumar S., Srinivasa S. V.* , Prabhakar K. Haematological profile of diabetes and non-diabetes patients in rural tertiary centre. IJAM;2017(4;Issue 5);1271-75.

Al Salhen, Khaled S, Mahmoud, Ameerah Y. Hematological profile of patients with type 2 Diabetic mellitus in El-Beida, Libya. Ibnosina J Med Biomed Sci. 2017;9(3):76-80.

Belete Biadgo, Mulugeta Melku, Solomon Mekonnen Abebe, Molla Abebe. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. DMSO 2016:9 91–99.


Refbacks

  • There are currently no refbacks.